Vimy Pharmaceuticals Inc.

New Filing

CIK: 0002159983·Pharmaceuticals·ONTARIO, CANADA·Filed: Nov 6, 2026

Total Offering

$278,174

Amount Sold

$278,174

Investors

2

First Sale

Oct 22, 2026

Offering Details

Type: Equity
Exemptions: Rule 506(b)
Entity Type: Corporation
Year Incorporated: 2024
Non-Accredited Investors: No

Related Persons

Name	Role
David John Suchon	Related Person
Farris Smith	Related Person
Darryl Firsten	Related Person
Riccardo Trecroce	Related Person
Christopher Burkett	Related Person

Company

Vimy Pharmaceuticals Inc.

2 BLOOR STREET WEST

TORONTO, A6, M4W1J5

416-254-4774

SEC Filing

0001493152-26-050479

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.